2008 annual financial data
Celldex Therapeutics 2008 Operating margin
Direct answer
Operating margin was -456.04%.
Operating income was -34,000,080 USD and net income was -47,500,571 USD.
Operating cash flow was 18,280,766 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,455,507 USD
- Operating income
- -34,000,080 USD
- Net income
- -47,500,571 USD
- Operating cash flow
- 18,280,766 USD